Abstract
Stressful experiences are a well-known risk factor for the development of psychiatric disorders such as depression (MDD). Although many pharmaceutical therapies have been developed, over half of individuals that seek treatment do not respond positively, indicating a dire need for new treatments and thus new molecular targets.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have